Dr. Stavas is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
8020 Arco Corporate Dr
Raleigh, NC 27617Phone+1 402-398-5890Fax+1 402-398-5583
Education & Training
University North CarolinaMPH, Health Policy/Management, Honors, 2009 - 2011
University of California (San Diego) Medical CenterResidency, Radiology-Diagnostic, 1986 - 1987
University of MinnesotaResidency, Radiology-Diagnostic, 1982 - 1986
Creighton University School of MedicineClass of 1982
Certifications & Licensure
- American Board of Radiology Pediatric Radiology
- American Board of Radiology Interventional Radiology and Diagnostic Radiology
Clinical Trials
- Acute Venous Thrombosis: Thrombus Removal With Adjunctive Catheter-Directed Thrombolysis Start of enrollment: 2009 Nov 01
Publications & Presentations
PubMed
- 1 citationsRilparencel (Renal Autologous Cell Therapy-REACT®) for Chronic Kidney Disease and Type 1 and Type 2 Diabetes: Phase 2 Trial Design Evaluating Bilateral Kidney Dosing a...Joseph Stavas, Arnold L Silva, Thomas D Wooldridge, Ahmed Aqeel, Theodore Saad
American Journal of Nephrology. 2024-01-01 - 1 citationsRenal Autologous Cell Therapy in Type 2 Diabetes with Late Stage 4 Diabetes-Related Chronic Kidney Disease: Trial Design and Early Analysis.Joseph Stavas, Bijin Thajudeen, Steven Coca, Arnold Silva, Emily Butler
Blood Purification. 2023-01-01 - 10 citationsRenal Autologous Cell Therapy to Stabilize Function in Diabetes-Related Chronic Kidney Disease: Corroboration of Mechanistic Action With Cell Marker Analysis.Joseph Stavas, Guido Filler, Deepak Jain, John Ludlow, Joydeep Basu
Kidney International Reports. 2022-07-01
Journal Articles
- Massive Inferior Vena Cava Thrombosis Associated with Retroperitoneal Venolymphatic MalformationRaviteja R Guddeti, Himanshu Agarwal, Joseph Stavas, ScienceDirect
Press Mentions
Diversity in Clinical Trials Leads to Richer DataApril 12th, 2023- ProKidney Announces Publication of Trial Design for Phase 2 Multicenter Clinical Trial of REACT for Late Stage 4 Diabetes-Related Chronic Kidney DiseaseJanuary 10th, 2023
- ProKidney to Present REACT® at 4th Annual CKD SummitMarch 1st, 2022
- Join now to see all
Industry Relationships
- SVP Clinical Development, ProKidney
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
